Impressive Data Sets from Big Pharma and Merck Spends $1.3B to Acquire Eyebiotech

Asahi Kasei announces the acquisition of Calliditas Therapeutics (CALT) for $1.1 billion. The M&A Train Never Stops!

Biotech Capital Market Environment Highlights - Earnings Season Wrapping Up with JNJ and Novartis Acquisitions